Excipient GMP Quality Standards: One is Enough

Lonza will work with Iconovo to develop spray-dried formulations for an intranasally delivered biologic using a reformulated biologic drug candidate for obesity.

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

The HTAR, which aims to increase access to new medicines, becomes effective Jan. 12, 2025.

In this episode, Alexander Natz from EUCOPE chats about the European Health Data Space.

Posdinemab is the second tau-directed investigational therapy by J&J that has received fast track designation from FDA this year for Alzheimer’s disease.

The AI Lab was launched almost exactly three years ago and has produced several programs so far, at least one of which achieved its first scientific stage gate 40% faster than the teams originally forecasted.